ERBB2 and hepatocellular carcinoma: In previous studies, Erb-B2 receptor tyrosine kinase 2 (ERBB2) and NUF2 component of the NDC80 Kinetochore Complex (NUF2) were reported to be biomarkers of hepatocellular carcinoma (HCC) recurrence after surgery.